Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial
- Resource Type
- Article
- Authors
- Adir, Yochai; Baillie, Timothy; Baratz, David; Burger, Charles; Chakinala, Murali M.; Cifrián Martínez, Jose Manual; Delcroix, Marion; Dwyer, Nathan; Elwing, Jean M.; Fisher, Micah; Franco, Veronica; Grünig, Ekkehard; Highland, Kristin; Hill, Nicholas; Hirani, Naushad; Hoeper, Marius; Jansa, Pavel; Keogh, Anne; Kingrey, John; Lopez-Meseguer, Manuel; McConnell, John W.; Mehta, Sanjay; Melendres-Groves, Lana; Opitz, Christian; Pepke-Zaba, Joanna; Pillutla, Priya; Rahaghi, Franck; Raina, Amresh; Raviv, Yael; Robinson, Jeffrey; Ryan, John; Sager, Jeffrey; Shapiro, Shelley; Simon, Marc; Smith, Kerri; Sobol, Irina R.; Sood, Namita; Spikes, Leslie A.; Stadler, Stefan; Stevens, Wendy; Sulica, Roxana; White, R. James; Frantz, Robert P ; McLaughlin, Vallerie V; Sahay, Sandeep; Escribano Subías, Pilar; Zolty, Ronald L; Benza, Raymond L; Channick, Richard N; Chin, Kelly M; Hemnes, Anna R; Howard, Luke S; Sitbon, Olivier; Vachiéry, Jean-Luc; Zamanian, Roham T; Cravets, Matt; Roscigno, Robert F; Mottola, David; Osterhout, Robin; Bruey, Jean-Marie; Elman, Erin; Tompkins, Cindy-ann; Parsley, Ed; Aranda, Richard; Zisman, Lawrence S; Ghofrani, Hossein-Ardeschir
- Source
- In The Lancet Respiratory Medicine July 2024 12(7):523-534
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600